These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19028266)

  • 21. Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease.
    Zhang J; Zhang B; Ren Q; Zhong Q; Li Y; Liu G; Ma X; Zhao C
    Neurol Sci; 2021 Jun; 42(6):2337-2345. PubMed ID: 33043395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oculomotor performance in children with high-functioning Autism Spectrum Disorders.
    Wilkes BJ; Carson TB; Patel KP; Lewis MH; White KD
    Res Dev Disabil; 2015 Mar; 38():338-44. PubMed ID: 25590171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Saccadic eye movements as a measure of the pharmacodynamics of benzodiazepines. Evaluation of various occulographic parameters].
    Schlaginhaufen W; Meienberg O; Fisch HU
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1984 Sep; 15(3):145-50. PubMed ID: 6435998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on eye movement studies in childhood and adolescent psychiatry.
    Rommelse NN; Van der Stigchel S; Sergeant JA
    Brain Cogn; 2008 Dec; 68(3):391-414. PubMed ID: 18835079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oculomotor abnormalities in schizophrenia: a critical review.
    Hutton S; Kennard C
    Neurology; 1998 Mar; 50(3):604-9. PubMed ID: 9521243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between alterations of eye movement control and cerebral intrinsic functional connectivity in Parkinson's disease.
    Gorges M; Müller HP; Lulé D; ; Pinkhardt EH; Ludolph AC; Kassubek J
    Brain Imaging Behav; 2016 Mar; 10(1):79-91. PubMed ID: 25749936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in eye tracking during clinical stabilization in schizophrenia.
    Rea MM; Sweeney JA; Solomon CM; Walsh V; Frances A
    Psychiatry Res; 1989 Apr; 28(1):31-9. PubMed ID: 2568005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of nicotine on specific eye tracking measures in schizophrenia.
    Sherr JD; Myers C; Avila MT; Elliott A; Blaxton TA; Thaker GK
    Biol Psychiatry; 2002 Oct; 52(7):721-8. PubMed ID: 12372663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oculomotor deficits in attention deficit hyperactivity disorder (ADHD): A systematic review and comprehensive meta-analysis.
    Maron DN; Bowe SJ; Spencer-Smith M; Mellahn OJ; Perrykkad K; Bellgrove MA; Johnson BP
    Neurosci Biobehav Rev; 2021 Dec; 131():1198-1213. PubMed ID: 34655657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smooth pursuit eye movements of patients with schizophrenia and affective disorder during clinical treatment.
    Flechtner KM; Steinacher B; Sauer R; Mackert A
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):49-53. PubMed ID: 12111336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of GABA.
    Meldrum B
    Clin Neuropharmacol; 1982; 5(3):293-316. PubMed ID: 6214305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of diphenhydramine on human eye movements.
    Hopfenbeck JR; Cowley DS; Radant A; Greenblatt DJ; Roy-Byrne PP
    Psychopharmacology (Berl); 1995 Apr; 118(3):280-6. PubMed ID: 7617820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of eye movement tasks as an aid to understanding Parkinson's disease pathophysiology.
    Fukushima K; Fukushima J; Barnes GR
    Exp Brain Res; 2017 May; 235(5):1309-1321. PubMed ID: 28258438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication adversely impacts visually-guided eye movements in Parkinson's disease.
    Munoz MJ; Reilly JL; Pal GD; Verhagen Metman L; Rivera YM; Drane QH; Corcos DM; David FJ; Goelz LC
    Clin Neurophysiol; 2022 Nov; 143():145-153. PubMed ID: 35995722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.
    Simeon J; Milin R; Walker S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):267-75. PubMed ID: 11817503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific oculomotor deficit after diazepam. I. Saccadic eye movements.
    Rothenberg SJ; Selkoe D
    Psychopharmacology (Berl); 1981; 74(3):232-6. PubMed ID: 6791230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.